|
A new approach to lowering cholesterol for that avoidant or intolerant to statins
|
|
Statin drugs remain the gold standard
when it comes to lowering LDL, also labeled ‘bad’ cholesterol, but many patients
at risk for heart disease are turned off by the severe side effects including muscle pain and
weakness. For those who refuse to take statin drugs, a replacement
treatment is necessary, and bempedoic acid, a daily pill with FDA
approval, is the newest and perhaps best alternative.
|
-
A new phase 3 placebo-controlled study featuring bempedoic acid,
a drug aimed to lower LDL while avoiding muscle aches and pains,
with 14,000 patients was found to modestly reduce the risk of heart
attacks, strokes, and other complications of heart disease.
-
The drug lowered LDL cholesterol by 21%, reduced myocardial
infarction by 23%, and reduced coronary revascularization by 19%.
-
Statins do remain as the first line of defense in lowering LDL and
protecting cardiac health, but for those who cannot tolerate statins,
bempedoic acid works effectively, and does not cause the muscle
pain that vilifies statins.
|
|
|